Billionaire Icahn Carl‘s Icahn Capital has filed an amended Form 13D with the US Securities and Exchange Commission, in which it reported raising its stake in Herbalife Ltd. (NYSE:HLF) to 21.44 million shares, which account for 23.05% of the float. As per the prior 13D filing on the company, the fund’s stake consisted of 19.3 million shares, which amassed 20.78% of the outstanding stock.
Herbalife is a world-renowned nutrition company that produces a variety of nutritional products. Since the beginning of the year, the company’s stock has gained 2.8%. For the third quarter of 2016, the company reported earnings per share of $1.21, topping the estimates of $1.09, and revenue of $1.12 billion, below the estimates of $1.14 billion. Recently, Pivotal Research reiterated its ‘Buy’ rating on the stock, with a price target of $90.
Out of the 749 hedge funds that we track which filed 13Fs for the end of June, 35 reported long positions in Herbalife (NYSE:HLF), down by two from the previous quarter. Among the largest investors in the company were William Duhamel’s Route One Investment Company (3.61 million shares), Jim Simons’ Renaissance Technologies (3.16 million shares), David Kowitz and Sheldon Kasowitz’s Indus Capital (2.63 million shares), and Vinit Bodas’ Deccan Value Advisors (2.13 million shares).
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|High River Limited Partnership||4,288,786||0||4,288,786||0||4,288,786||4.61%|
|Icahn Partners Master Fund||6,980,001||0||6,980,001||0||6,980,001||7.50%|
|Icahn Enterprises Holdings||0||17,155,145||0||17,155,145||17,155,145||18.44%|
|Icahn Enterprises G.P. Inc||0||17,155,145||0||17,155,145||17,155,145||18.44%|
|Carl C. Icahn||0||21,443,931||0||21,443,931||21,443,931||23.05%|
|Date of Transaction Amount of Securities Price Per Share High River Limited Partnership|
Page 1 of 16 – SEC Filing